TP53 and cancer: These findings are in line with somatic TP53 mutations accumulating preferentially in tissues arising from the embryonic layers of the ectoderm and the endoderm, in contrast to germline TP53 mutations which at least for non-reproductive cancers, preferentially occur in tissues derived from the mesoderm23, which includes the kidney.